financetom
Business
financetom
/
Business
/
US health chief says not enough data to show Tylenol causes autism, but still advises caution
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US health chief says not enough data to show Tylenol causes autism, but still advises caution
Oct 29, 2025 11:23 AM

WASHINGTON, Oct 29 (Reuters) - U.S. Health Secretary

Robert F. Kennedy Jr. on Wednesday said there is not enough

evidence to show that Kenvue's ( KVUE ) pain medicine Tylenol

definitively causes autism, but said that it should still be

used cautiously in consultation with a physician.

"The causative association ... between Tylenol given in

pregnancy and the perinatal periods is not sufficient to say it

definitely cause autism. But it is very suggestive," he told

reporters. "And it's suggestive to animal studies and core blood

studies and observational studies from nation to nation. And so

there should be a cautious approach to it."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Empire Expands Partnership With FoodHero Beyond Quebec
Market Chatter: Empire Expands Partnership With FoodHero Beyond Quebec
Jul 16, 2024
09:42 AM EDT, 07/16/2024 (MT Newswires) -- Empire Company (EMP-A.TO) is expanding its partnership with FoodHero, the Montreal-based app, to reduce food waste beyond Quebec, reports Canadian Press. According to the report, the partnership is expanding to new regions, including Ontario, Atlantic Canada and Western Canada. The FoodHero app connects shoppers to stores offering 60% discounts in Quebec and 50%...
--Ally Financial Keeps Quarterly Dividend at $0.30 a Share, Payable Aug. 15 to Shareholders as of Aug. 1
--Ally Financial Keeps Quarterly Dividend at $0.30 a Share, Payable Aug. 15 to Shareholders as of Aug. 1
Jul 16, 2024
09:39 AM EDT, 07/16/2024 (MT Newswires) -- Price: 43.65, Change: -0.13, Percent Change: -0.30 ...
Senti Biosciences Board Authorizes 1-for-10 Reverse Stock Split; Shares Fall
Senti Biosciences Board Authorizes 1-for-10 Reverse Stock Split; Shares Fall
Jul 16, 2024
09:44 AM EDT, 07/16/2024 (MT Newswires) -- Senti Biosciences ( SNTI ) said Tuesday that its board has authorized a 1-for-10 reverse stock split. Shares in the biotech firm will begin trading on a split-adjusted basis at the start of trading on Thursday. The move, which will reduce the number of outstanding shares to about 4.6 million from about 45.8...
Atlassian Gets 'In Process' FedRAMP Status
Atlassian Gets 'In Process' FedRAMP Status
Jul 16, 2024
09:40 AM EDT, 07/16/2024 (MT Newswires) -- Atlassian ( TEAM ) said Tuesday it has obtained an In Process status with the US Federal Risk and Authorization Management Program, or FedRAMP, and is now listed on the FedRAMP marketplace. The company anticipates receiving the FedRAMP Moderate Authority to Operate for its Atlassian Government Cloud in Q1 next year, Atlassian (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved